Long-lasting antiamnesic effect of a novel anticholinesterase inhibitor (MF268)

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 4, 1998, Pages 897-901

  Braida, Daniela ^a   Paladini, Emma ^a   Griffini, Pierluigi ^b   Lamperti, Mariapia ^b   Colibretti, Luisa ^b   Sala, Mariaelvina ^a  

^a Institute of Pharmacology   (Italy)

^b Mediolanum Farmaceutici   (Italy)

Author keywords

Brain cholinesterase; E2020; Inhibition; Locomotor activity; MF268; Radial maze; Rat; Tacrine

Indexed keywords

(3A,8A) 1,2,3,3A,8,8A HEXAHYDRO 1,3A,8 TRIMETHYLPYRROLO[2.3B]INDOL 5 OL[8(2.6 DIMETHYLMORPHOLIN 4 YL)OCTYL]CARBAMATE BITARTRATE HYDRATE; CHOLINESTERASE INHIBITOR; DONEPEZIL; MF 268; SCOPOLAMINE; TACRINE; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINESTERASE INHIBITION; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; ENZYME KINETICS; MALE; MAZE TEST; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

AMNESIA; ANIMALS; BRAIN; CHOLINESTERASE INHIBITORS; COGNITION; INDANS; MALE; MAZE LEARNING; MORPHOLINES; MOTOR ACTIVITY; MUSCARINIC ANTAGONISTS; PIPERIDINES; RATS; RATS, WISTAR; SCOPOLAMINE; TACRINE;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0032052203     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00526-1     Document Type: Article

References (16)

1. Anisman H., Kokkinidis L. Effects of scopolamine, d-amphetamine and other drugs affecting catecholamines on spontaneous alternation and locomotor activity in mice. Psychopharmacology (Berlin). 45:1975;55-64.
2. Barenghi L., Ceriotti F., Luzzana M., Ripamonti M., Mosca A., Bonini P. A. Measurement of erythrocyte acetylcholinesterase and plasma cholinesterase activity by a differential pH technique. Ann. Clin. Biochem. 23:1986;538-545.
3. Braida D., Paladini E., Griffini P., Lamperti M., Maggi A., Sala M. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats. Comparison with other cholinesterase inhibitors Eur. J. Pharmacol. 302:1996;13-20.
4. Cuadra G., Summers K., Giacobini E. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo. J. Pharmacol. Exp. Ther. 270:1994;1-8.
5. Eisai, Co. Ltd. (Japan): E2020. Drugs of the future. 16:16-18; 1991.
6. Flood J. F., Landry D. W., Jarvik M. E. Cholinergic receptor interaction and their effects on long-term memory processing. Brain Res. 215:1981;177-185.
7. Giacobini E., Zhu X.-D., Williams E., Sherman K. A. The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amines levels in rat cortex. Neuropharmacology. 35:1996;205-211.
8. Gracon S. I., Knapp M. J. Tacrine. An overview of efficacy in two parallel group studies Giacobini E., Becker R. Alzheimer disease. Therapeutic strategies:1994;145-149 Birkhauser, Boston.
9. Imbimbo B. P., Lucchelli P. E. A pharmacodynamic strategy to optimize the clinical response to eptastigmine (MF201). Giacobini E., Becker R. Alzheimer disease. Therapeutic strategies:1994;99-102 Birkhauser, Boston.
10. Magnani M., Pozzi O., Biagetti R., Banfi S., Dorigotti L. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze. Psychopharmacology (Berlin). 106:1992;175-178.
11. Messamore E., Warpman U., Ogane N., Giacobini E. Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex. Neuropharmacology. 32:1993;745-750.
12. Sala M., Braida D., Calcaterra P., Leone M. P., Comotti F. A., Gianola S., Gori E. Effect of centrally administered atropine and pirenzepine on radial arm maze performance in the rat. Eur. J. Pharmacol. 194:1991;45-49.
13. Steel R. G., Torrie J. H. Principles and procedures of statistics. 1960;Mc Graw-Hill Book Company, New York.
14. Waite J. J., Thal L. J. The behavioral effects of heptylphysostigmine on rats lesioned in the nucleus basalis. Neurosci. Res. 21:1995;251-259.
15. Wanibuchi F., Nishida T., Yamashita H., Hidaka K., Koshiya S., Tsukamoto S., Usuda S. Characterization of a novel muscarinic receptor agonist, YM796. Comparison with cholinesterase inhibitor in vivo pharmacological studies Eur. J. Pharmacol. 265:1994;151-158.
16. Zhu X.-D., Cuadra G., Brufani M., Maggi T., Pagella P. G., Williams E., Giacobini E. Effects of MF268 a new cholinesterase inhibitor on acetilcholine and biogenic amines in rat cortex. J. Neurosci. Res. 43:1996;120-126.